COMPANY

    ABOUT US

    D5 Therapeutics is a leading biotechnology company that is discovering novel target and developing innovative medicines  in a conceptual frame of synthetic
    lethality leveraging data-driven platform technology.



    We identify and validate potential SL targets and characterize SL interactions through D5’s comprehensive SL prediction platform that integrated computational and
    experimental framework.



    With D5’s platform, we will not only expand our SL pipeline but also collaborate with a various global partners to develop more accurate and effective treatment options for
    cancer patients.